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Abstract
Background: The mitochondria are essential organelles and are the location of cellular respiration, which is
responsible for the majority of ATP production. Each cell contains multiple mitochondria, and each mitochondrion
contains multiple copies of its own circular genome. The ratio of mitochondrial genomes to nuclear genomes is
referred to as mitochondrial copy number. Decreases in mitochondrial copy number are known to occur in many
tissues as people age, and in certain diseases. The regulation of mitochondrial copy number by nuclear genes has
been studied extensively. While mitochondrial variation has been associated with longevity and some of the
diseases known to have reduced mitochondrial copy number, the role that the mitochondrial genome itself has in
regulating mitochondrial copy number remains poorly understood.
Results: We analyzed the complete mitochondrial genomes from 1007 individuals randomly selected from the
Cache County Study on Memory Health and Aging utilizing the inferred evolutionary history of the mitochondrial
haplotypes present in our dataset to identify sequence variation and mitochondrial haplotypes associated with
changes in mitochondrial copy number. Three variants belonging to mitochondrial haplogroups U5A1 and T2 were
significantly associated with higher mitochondrial copy number in our dataset.
Conclusions: We identified three variants associated with higher mitochondrial copy number and suggest several
hypotheses for how these variants influence mitochondrial copy number by interacting with known regulators of
mitochondrial copy number. Our results are the first to report sequence variation in the mitochondrial genome
that causes changes in mitochondrial copy number. The identification of these variants that increase mtDNA copy
number has important implications in understanding the pathological processes that underlie these phenotypes.
Background
Mitochondria are the location of the citric acid or Krebs
Cycle, which produces the majority of ATP for cellular
work. Each cell has multiple mitochondria and each
mitochondrion contains one or more copies of its own
circular genome (mtDNA), which is 16569 bases in
length and encodes 37 genes. Mitochondria are neces-
sary for survival and malfunctioning mitochondria are
the cause of a variety of diseases [1-11]. Mitochondrial
diseases tend to affect the CNS or muscle tissue because
of the high energy needs of these tissues [12]. Mito-
chondrial diseases have been well studied and can be
the result of genetic variation in the mitochondrial and/
or nuclear genomes. Pathogenic nuclear mutations are
inherited in a typical Mendelian pattern and can present
with a dominant, recessive, or X-linked dominant or
recessive inheritance pattern. Examples of mitochondrial
diseases caused by mutations in the nuclear genome1Department of Biology, Brigham Young University, Provo, UT, USA
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include Friedrich’s ataxia [13], Wilson’s disease [14], and
Barth syndrome [15].
In contrast, mitochondrial diseases caused by variation
in the mtDNA are not as straightforward. Mitochondria
are maternally inherited, so mitochondrial disease caused
by these variants will display maternal inheritance. How-
ever, in most cases both normal and pathogenic mtDNA
are inherited together and the mix can vary from predomi-
nantly wild type to predominantly pathogenic. Depending
on the severity of the mutation, proportion of wild type
versus affected mitochondria, and the specific tissue, there
may or may not be a disease phenotype. Over the course
of life the proportion of diseased mitochondria can
change, possibly reaching a critical threshold at which the
disease phenotype is expressed. Alternatively, a constant
proportion of diseased mitochondria might contribute to
disease only when present in combination with one or
more additional factors (e.g. stresses of various kinds, and/
or aging). In addition to inherited mtDNA variation,
mtDNA is prone to somatic mutations [16], and if affected
mtDNA are propagated they can eventually reach a
threshold at which mitochondrial function is insufficient
to support normal cellular functions and disease appears.
Some examples of disorders caused by mtDNA mutations
are Kearns-Sayre syndrome [8], diabetes mellitus and deaf-
ness [7], Leber’s hereditary optic neuropathy [9], Leigh
Syndrome [11], and Myoclonic Epilepsy with Ragged Red
Fibers (a.k.a. MERRF syndrome) [10].
Additionally, mitochondria have a role in aging. The
free-radical theory of aging, or mitochondrial free radical
theory of aging, hypothesizes that aging occurs as damage
from reactive oxygen species (ROS) accumulates. ROS
are produced in the electron transport chain [17] and
readily oxidize DNA and RNA, amino acids, and fatty
acids [18-20]. Damage from ROS can accumulate with
time resulting in cellular dysfunction, and death [21].
MtDNA copy number, or the cellular ratio of mito-
chondrial genomes to nuclear genomes, decreases with
age in some, but not all, tissues [22-25] and mtDNA
copy number variation has been associated with numer-
ous phenotypes [26-38]. MtDNA copy number is tissue
dependent [39] and varies with age and the energy
needs of the cell [24,25,40].
Several nuclear genes regulate mtDNA copy number.
First, there is substantial evidence that mitochondrial
transcription factor A (TFAM) regulates mtDNA copy
number [41-44]. The Mec1/Rad53 (yeast) pathway has
been implicated in controlling mtDNA copy number,
and mtDNA levels can be controlled by any of several
genes responsible for regulating the pathway [45]. p53
deficient cells or mutated p53 leads to decreased levels of
mtDNA [46]. Two common nuclear SNPs in signal trans-
ducer and activator of transcription 3 (STAT3) were sig-
nificantly associated with mtDNA levels in leukocytes
[47]. Both the Ras pathway and p66Shc likely have roles in
regulating mtDNA copy number [48]. MnSOD prevents
decreases in mtDNA levels by preventing a decrease in
mtDNA replication proteins [49]. And finally, overexpres-
sion of Twinkle increases mtDNA copy number [50].
The direct role for the mitochondrial genome regulat-
ing levels of mtDNA has not been studied extensively.
Here we conduct a genetic association study of full
mitochondrial genome data and mtDNA copy number
in individuals from the Cache County Study on Memory
Health and Aging. Our results identify association
between mitochondrial haplogroups U5A1 and T2 and
increased mtDNA copy numbers.
Methods
Ethics statement
As described in [51], all study procedures were approved
by the Institutional Review Boards of Brigham Young Uni-
versity, Utah State University, Duke University, and Johns
Hopkins University. Written consent was obtained for
each individual. To verify a subject’s capacity to consent,
subjects attempted the Modified Mini-Mental State Exam
(3MS). If there was an indication of poor cognitive ability
as determined by poor performance on the entire test
(scoring below a designated total of 60 points), poor per-
formance on temporal or spatial orientation, or clear diffi-
culty in understanding the nature of the interview, the
visit was discontinued and informed consent was obtained
from a responsible caregiver- often the next-of-kin.
We re-consented subjects/caregivers at each study visit
and procedure.
Sample acquisition and sequencing
Samples for this study were selected from the Cache
County Study on Memory Health and Aging [52]. This
study was initiated in 1994 to investigate associations of
genetic and environmental factors with cognitive function.
In 1994, the 5,092 individuals enrolled in the study from
Cache County, Utah, represented 90% of all Cache
County, Utah, residents who were 65 or older. The cohort
was followed for 12 years and data (medical histories,
demographics, and a multistage dementia assessment)
were collected in four triennial waves. The Utah popula-
tion is similar to other U.S. populations of northern Eur-
opean ancestry characterized by very little inbreeding. The
founding group of Utah’s population was unrelated and
migrated from various locations in Europe [53-55].
The Utah Population database (UPDB) has complete
pedigree information going back 14 generations to the ori-
ginal Utah Founders. Using this information we identified
individuals from the Cache County Study with the same
maternal line of inheritance (matrilineage). We randomly
selected one individual from each matrilineage, selecting
individuals from the largest matrilineages first to maximize
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our ability to infer mitochondrial genomic information.
Given our resources, we were able to sequence a represen-
tative sample from 274 of the 3151 matrilineages that exist
in the Cache County Study samples. The sequenced mito-
chondrial genomes represent many different major mito-
chondrial haplogroups (Table 1). 287 samples were sent to
Family Tree DNA (http://www.familytreedna.com) for
Sanger sequencing of the mitochondrial genomes. Two
samples failed quality control at Family Tree DNA. Based
on maternal inheritance of the mtDNA we inferred that
individuals who share matrilineal relationships have the
same mtDNA. Using this we inferred the status of full
mitochondrial genome sequence for 722 additional indivi-
duals for a total of 1007 individuals, not accounting for de
novo mutation. The extensive pedigree data in the UPDB
allows identification of shared maternal lineages for very
distant relationships. As this was a population-based study
it is one generation in depth, but there are extended famil-
ial relationships, even very distant cousins. Ridge et al [51]
contains additional details about the sequencing and infer-
ence of the mtDNA status in this dataset.
Measurement of mtDNA copy number
Relative quantitation of the ratio of the copy number of
the mitochondrial genome to the copy number of the
nuclear single copy gene beta-globin, as compared to that
ratio in a reference DNA sample, was determined by
monochrome multiplex quantitative polymerase chain
reaction (QPCR). Buccal sample cell lysates were diluted
in water (containing yeast total RNA as carrier, at 2.5 ng
per microliter) to a final total cellular DNA concentration
of approximately 1 ng per 10 microliters. QPCR was
carried out in 25 microliter reactions, containing 10
microliters of the diluted buccal lysate and 15 microliters
of QPCR reagent mix with primers.
The QPCR reagent mix, without primers, was exactly as
described by Cawthon [56]. The primers for mtDNA
amplification were mt3257u, 5’- GCAGAGCCCGG-
TAATCGCA-3’, and mt3272d, 5’-TAAGAAGAGGAAT
TGAACCTCTGACTGTAA-3’. The mt3272d primer has
previously been shown to be specific to mtDNA and
unable to amplify any nuclear-embedded mtDNA-like
sequences (numts) from rho 0 cell line DNA [57] (Rho 0
cell lines are mtDNA-free). The primers for the beta-glo-
bin gene were hbgugc2, 5’-CGGCGGCGGGCGGCG
CGGGCTGGGCGGCTTCATCCACGTTCACCTTG-3’,
and hbgdgc2, 5’-GCCCGGCCCGCCGCGCCCGTCCCGC
CGGAGGAGAAGTCTGCCGTT-3’. Both beta-globin pri-
mers contained 5’ GC-clamp (non-templated) sequences
that confer a high melting temperature on their amplicon.
Each of the four primers was present at a final concentra-
tion of 900 nM.
The thermal profile for QPCR began with 95 degrees C
for 15 minutes to activate the hot-start polymerase and
fully denature the DNA; followed by 35 cycles of: 94
degrees for 15 sec, 62 degrees for 20 sec, 72 degrees for
15 sec with signal acquisition (to read the mtDNA amplifi-
cation signal), 84 degrees for 10 sec, and 88 degrees for
15 sec (to read the beta-globin signal). In this mono-
chrome multiplex QPCR (MMQPCR) strategy, first
described by Cawthon [56], the higher copy number target
(in this case mtDNA) has its amplification signal collected
over a cycle range in which the lower copy number target’s
(in this case the beta-globin genes) amplification signal is
still at baseline, and the lower copy number target’s ampli-
ficaton signal is collected in later cycles, at a temperature
that is sufficiently high to completely melt the amplicon of
the higher copy number target, driving its signal to base-
line so that the signal from the high melting amplicon can
be cleanly read. All QPCR runs were done on Bio-Rad
MyiQ real-time machines, using the manufacturer’s
accompanying software. The Standard Curve method for
relative quantitation was used, with 36 ng of a reference
DNA sample as the high end, and four additional standard
concentrations obtained via 3-fold serial dilutions from
the high end. Each subject’s buccal lysate was assayed in
triplicate. The average of the three measurements for each
sample was used in this study (Additional File 1). DNA
is not available from other tissue for the majority of these
samples.
Sequence and statistical analyses
We used ClustalW [58] to align the mitochondrial gen-
omes and inferred a haplotype network using TCS [59]
and the 285 sequenced mitochondrial genomes. In a hap-
lotype network, segments of branches correspond to a
single sequence feature (single nucleotide variant, indel,
Table 1 Distribution of major mtDNA haplogroups/
clusters.














Here we report the number of individuals belonging to each of the major
haplogroups represented in our dataset along with case-control status. This
Table first appeared in [51]. 1Missing major haplogroup
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etc.), and nodes in the network correspond to haplotypes.
Branches, comprised of one or more segments, connect
observed nodes, while clades are comprised of one or
more observed nodes, and are defined by a branch.
Genotype-phenotype associations were evaluated using
an evolution-based method known as TreeScanning
[60,61] that makes use of haplotype networks. Haplotype
networks provide a framework from which to select evo-
lutionarily related haplotypes to pool together for com-
parison. Additional details about the application of
TreeScanning to this dataset can be found in Ridge et al
[51]. The null hypothesis of TreeScanning is that the
phenotype does not differ in distribution across the gen-
otypes derived from allelic classes defined by the
branches of the haplotype network. Each branch parti-
tions the haplotypes into bi-allelic pools from which
genotypes are constructed and treated as a separate test.
Because we have multiple tests that are correlated we
obtained multiple-test corrected p-values by a permuta-
tion analog of the sequential step-down Bonferroni [62]
with 10,000 permutations. If significant branches are
found in the first round of TreeScanning, a second
round of TreeScanning is performed that can detect
phenotypic heterogeneity within the allelic classes of the
significant branch. This is accomplished by creating a
three-allele system and using conditional permutations
that hold one of the alleles constant while subdividing
the other class into two alleles [60]. Significant branches
define clades.
For these analyses we tested for association with mito-
chondrial copy number after adjusting for gender, age,
and familial relationships. Familial adjustment scores,
which quantify the variance in mtDNA copy number
that is due to familial relationships between individuals
in the dataset, were computed using the method devel-
oped by Kerber (modified for a continuous trait) [63].
For each individual we summed the products of the
mtDNA copy number and the pairwise kinship coeffi-
cient (a pairwise measure of relatedness) with each of
the other individuals in the sample. This sum is then
divided by the total number of samples in the dataset.
Finally, we divide by the mtDNA copy number of the
individual, yielding a value, which represents the rela-
tionship between mtDNA copy number and relatedness
to other individuals in the dataset. We calculated famil-
ial adjustment scores for each individual in the dataset
using the following equation:
familial adjustment score =
∑N
j=1 copy number j ∗ f (individual, j)
N
individual copy number
Where N is the number of individuals in the cohort
and f(individual, j) is the kinship coefficient between the
individual for whom we are calculating a familial
adjustment score (labeled as ‘individual’ in the formula)
and individual j (representing each of the other indivi-
duals in the dataset one at a time). Inclusion of this
score as a covariate in our analyses removes variance in
mtDNA copy number that is due to relatedness between
individuals, making it possible to test for association
independently of pedigree relationships in the data. This
adjustment addresses both maternal and paternal rela-
tionships in the data, thus correcting for possible
nuclear genomic confounds as well. Each analysis was
performed with 10,000 permutations. Only tests with at
least two relevant genotypic classes, each containing five
or more individuals, were tested. Significance was
inferred if the multiple-test-corrected p-value was less
than 0.05.
Bioinformatic analyses of variants
In order to determine the functional impact of variants of
interest we applied in silico functional prediction algo-
rithms, analyzed pathways, examined protein sequence
conservation, and identified conserved domains. We
obtained protein sequences from NCBI using blast [64],
aligned and analyzed them using the CLCViewer (http://
clcbio.com/), identified conserved domains using the
NCBI conserved domain database [65], identified pathways
using Ingenuity (http://Ingenuity.com/), and obtained
functional predictions from polyphen-2 [66] and SIFT
[67,68] webservers. In each case we used default settings.
Results
Haplotype network and mtDNA variation
We sequenced 285 complete mitochondrial genomes
from individuals in the Cache County Study on Memory
Health and Aging and imputed 722 additional full mito-
chondrial genomes using maternal lineages for a full
dataset of 1007 full mitochondrial genomes. We built our
network using the 285 genotyped individuals (Additional
Files 2, 3). Our network contained 249 different haplo-
types and the majority of haplotypes (152 of 249) were
observed in three or fewer individuals with the two most
frequently observed haplotypes observed in 39 and 32
individuals, respectively. Our network contained one
unresolved loop and the ambiguity was factored into sub-
sequent analyses.
We identified 899 single nucleotide variants (SNVs),
26 insertions, and 20 deletions in our dataset. The most
frequently observed SNVs occurred in 281 genomes
(m.263A>G, m.8860A>G, and m.15326A>G), and three
more SNVs were observed in 280 genomes (m.750A>G,
m.1438A>G, and m.4769A>G). Compared to the reference
sequence (NC_012920), each person had an average of
25.3 variants (52 variants were the most identified in a sin-
gle individual and 2 variants the fewest, each extreme
observed in one person).
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The distribution of major mitochondrial haplogroups
within our dataset is reported in Table 1 (major mitochon-
drial haplogroups/clusters) and Additional File 4 (major
mitochondrial haplogroups and sub-haplogroups). Our
dataset contained individuals from 102 major mitochon-
drial haplogroups/clusters (or sub-haplogroups) in our
dataset. As expected, the majority (987 of 1007) of indivi-
duals in our dataset belonged to European-based major
mitochondrial haplogroups. We identified three different
branches, corresponding to two different clades, signifi-
cantly associated with mtDNA copy number.
Branches 124 and 121 are associated with mtDNA copy
number
First, branches 124 and 121, p-values of 8.0e-4 and 0.0043
(multi-test corrected p-values), respectively (Table 2,
Figure 1), were associated with higher mtDNA copy num-
ber. The clade defined by branch 121 is wholly contained
within branch 124 (Figure 2); therefore, these two
branches are highly correlated and represent the same
effect. Branch 124 is defined by a single variant (Table 3),
m.9667A>G. This is a missense variant, p.Asn154Ser,
located in cytochrome C oxidase 3 (COXIII). Branch 121
is defined by two variants (Table 3), m.12582A>G and
m.12879T>C, both synonymous variants in NADH dehy-
drogenase 5 (ND5).
Since these two branches correspond to a single effect
and branch 121 is wholly contained within branch 124, we
consider only the clade defined by branch 124 from this
point forward. This clade contains 14 individuals for whom
we have mtDNA copy number measurements. Pairwise
kinship coefficients are reported for these individuals in
Additional File 5. Individuals in this clade have a mtDNA
copy number nearly 50% higher (3.81 compared to 2.69,
p-value 8.0e-4) than individuals in the rest of the dataset.
All of the individuals in the clade defined by branch
124 belong to major mitochondrial haplogroup U5A1,
and have one of four different haplotypes (represented by
nodes in Figure 2). Nine other individuals (five different
haplotypes) in the dataset also belong to U5A1. These
individuals are located in adjacent clades to the one
defined by branch 124 and have significantly lower
mitochondrial copy numbers than the other U5A1 indivi-
duals (p-value 0.0082). The contrast of all U5A1 indivi-
duals against the rest of the dataset was nominally
significant (p-value 0.0019). While no d-loop variants
define branch 124, m.16399A>G, a d-loop variant, is only
found in the U5A1 individuals in our dataset and in gen-
eral appears to be found in all U5A1 individuals [69].
Branch 50 is associated with mtDNA copy number
Branch 50 is the third branch significantly associated
higher mtDNA copy number (p-value 0.015, multi-test
corrected p-value, Table 2 Figure 1). This represents a sta-
tistically separate effect as we controlled for the effect of
branch 124 in our analyses (just as we controlled for
branch 50 in our analyses of branch 124). Eight sequence
features define branch 50: seven single nucleotide variants
and one nine base pair deletion (Table 3). Six of the eight
features are intergenic or synonymous, but the other two
are both missense variants. m.5277T>C (p.Phe270Leu) is a
missense variant in NADH dehydrogenase 2 (ND2) and
m.6489C>A (p.Leu196Ile) is a missense variant in cyto-
chrome C oxidase 1 (COXI).
In the clade defined by branch 50 there are 12 indivi-
duals with mtDNA copy number measurements. Pairwise
kinship coefficients are reported for these individuals in
Additional File 6. The average mtDNA copy number for
individuals in this clade is 3.64 and is significantly higher
than the average for the rest of the dataset (2.69, p-value
0.015). Individuals in this clade belong to major mito-
chondrial haplogroup T2 and all have the exact same
haplotype. There were no other T2 individuals in the rest
of our dataset; however, there were T2A, T2B, T2C, and
T2E individuals. The contrast between T2 and all T2
sub-haplogroups (T2A, T2B, T2C, and T2E) and the rest
of the data was nominally significant, p-value 0.019, and
the contrast of T2B individuals alone against the rest of
the dataset was nominally significant, p-value 0.0062.
G, branch 124",1,0,1,0,0pc,0pc,0pc,0pc>Bioinformatic
Analyses of m.9667A>G, branch 124
m.9667A>G is the defining sequence change between the
U5A1 individuals in our dataset who had significantly
Table 2 Demographic information for significant contrasts.
Individuals/Missing p-value1 p-value2 Age Male/Female Mean copy #
Nominal Corrected Nominal Corrected
Whole network 1007/193 N/A N/A N/A N/A 75.6 442/565 2.69
Branch 124 17/3 0 6.0e-4 0 8.0e-4 75.2 9/8 3.81
Branch 121 10/1 0 0.002 1.0e-4 0.0043 76.3 4/6 4.01
Branch 50 15/3 2.0e-4 0.017 2.0e-4 0.015 78.4 7/8 3.64
Here we report demographic information for each of the significant contrasts and for all the individuals in the dataset. The clade represented by Branch 121 is
wholly contained within Branch 124, so these two contrasts represent a single effect. Branches 124 and 50 represent separate effects. Missing refers to the
number of individuals for whom we have no mtDNA copy number measurement.1p-values were calculated controlling only for the other significant branches
2p-values were calculated using age, gender, mtDNA copy number family risk score, and the other significant effects as covariates
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higher mtDNA copy number levels from the other U5A1
individuals in our dataset whose copy number measure-
ments were not statistically different from the rest of the
dataset. m.9667A>G causes an amino acid substitution,
asparagine to serine, at position 154 of COXIII, which is
located in an 11 residue stretch between transmembrane
domains. Since this is a missense mutation, we sought to
determine if it changes or inhibits COXIII and/or the
cytochrome c oxidase complex. We compared COXIII
sequences in organisms from humans through yeast by
aligning a 41-residue stretch of COXIII. In Figure 3, posi-
tion 154 of COXIII (the position of the amino acid substi-
tution corresponding to m.9667A>G) is in position 21 of
the alignment. As seen in Figure 3, two different amino
acids appear in this position: asparagine and glycine.
Asparagine and glycine are both uncharged amino acids;
however, asparagine is polar, whereas glycine is nonpolar.
M.9667A>G results in serine replacing asparagine. Serine
is polar and similar in size to asparagine (asparagine 132.1
g/mol, glycine 75.1 g/mol, and serine 105.1 g/mol).
We further analyzed the effect of this substitution on
COXIII by using in silico algorithms that predict the
effect of amino acid substitutions on protein function
using a variety of criteria such as conservation, amino
acid biochemical properties, known domains/structures
of the protein, etc. Polyphen-2 predicted the substitution
to be benign and SIFT predicted a pathogenic mutation,
but noted that its prediction was of very low confidence.
Lastly, we looked at possible interactions of COXIII with
known regulators (listed in the Introduction) of mtDNA
copy number to identify mechanisms m.9667A>G could
cause the increased copy number. We found common
regulators of both COXIII and the mtDNA copy number
regulators, and we found ways that these regulators could
affect COXIII expression; however, we identified no
pathways by which COXIII could regulate mtDNA copy
number by known mechanisms (Figure 4).
C and m.6489C>A, branch
50",1,0,1,0,0pc,0pc,0pc,0pc>Bioinformatic Analyses of
m.5277T>C and m.6489C>A, branch 50
It is more difficult to say which variants are causing the
increase in mtDNA copy number for the clade-defined by
branch 50 since this branch consists of eight different
sequence features. We chose to focus our analyses on two
of the features: m.5277T>C and m.6489C>A since these
Figure 1 Box plot comparing mitochondrial copy number between different clades. The grey dots represent the mitochondrial copy
number for each member of the representative groups. The top and bottom of the boxes correspond to the 75th and 25th percentiles, respectively,
and the line through the box is the median mitochondrial copy number for the group. The whiskers correspond to the maximum and minimum
mitochondrial copy numbers for the group. Three different groups are represented here: the clades defined by branches 124 and 50, and a group
containing all other individuals in the dataset. The y-axis is the mitochondrial copy number. The reported p-values are corrected.
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two variants are missense variants and the six others fea-
tures are either synonymous or intergenic changes.
First, m.5277T>C results in a phenylalanine to leucine
change in ND2. Position 270 of ND2 is column 21 in
Figure 5. At this position, primates have phenylalanine
and other species before have leucine. p.Phe270Leu
changes the human sequence back to the historical resi-
due. Polyphen-2 and SIFT predict that this substitution
is benign and tolerated, respectively.
Next, m.6489C>A causes a leucine to isoleucine
change at position 196 of COXI. This region of COXI is
highly conserved. Position 196 is leucine in every species
we examined from humans to yeast except nematodes
that have valine at this position (Figure 6). Polyphen-2
predicts that this substitution is probably damaging, and
SIFT also predicts that this substitution affects function,
but it is a low confidence prediction. Lastly, we identi-
fied pathways in which COXI malfunction could cause
an increase in mtDNA copy number. First we analyzed
pathways for all nuclear genes known to modify mtDNA
copy number and found no obvious pathways for genes
other than p53 and TFAM. We identified several path-
ways in which COXI malfunction could change mtDNA
copy number, the majority of which function through
intermediate genes activated by reactive oxygen species
(Figure 7).
Discussion
Using 1007 full mitochondrial genome sequences we
have identified sequence variation in mtDNA that affects
mtDNA copy number. Two different clades were signifi-
cantly associated with higher mtDNA copy number.
Each of these clades represents statistically separate
effects. The first was defined by branch 124 and con-
sisted of individuals with haplogroup U5A1, and is
defined by m.9667A>G (p.Asn154Ser). This variant has
also been reported in D2A1, D4M1, and J1B2A hap-
logroups [69]; however, no individuals in our dataset
Figure 2 Significant branches. This is a subset of the full haplotype network (Additional File 2), focused on the two significant clades defined
by branches 124 and 121, which are labeled here. The blue ovals represent haplotypes observed in our dataset, and the smaller white circles are
unobserved haplotypes. Only the variants that define branches 124 and 121 are labeled.
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belong to these haplogroups. We analyzed this substitu-
tion to determine if it likely causes COXIII malfunction,
and then to determine whether or not it could cause the
observed increase in mtDNA copy number. Our analyses
suggest this substitution does not impact COXIII function.
This conclusion is based on several lines of evidence; first,
this is a high frequency, known substitution [70], second
the substitution occurs in an unconserved site (Figure 3),
third asparagine and glycine, two very different amino
acids, appear historically in this position and a change
from asparagine to the more similar serine is likely to be
tolerated, and finally this position is in a short stretch of
sequence located between transmembrane domains and is
not a known position of importance in the heme-copper
oxidase subunit III super family, of which it is a part.
While it seems likely this variant does not disrupt
COXIII function, it is still possible that it could alter pro-
tein-protein interactions or specific dynamics associated
with the electron transport chain and ultimately lead to
changes in mtDNA copy number. Our initial analyses of
known regulators of mtDNA copy number with COXIII
(Figure 4) revealed no obvious mechanism for COXIII to
directly modify mtDNA copy number; however, Pello et
al [71] reported that m.9667A>G causes respiratory chain
assembly deficiencies in patients with Leber’s hereditary
optic neuropathy. TFAM (the main known regulator of
mtDNA copy number) concentration and mtDNA copy
number are proportional [42]; therefore, upregulators of
TFAM increase mtDNA copy number. TFAM is regu-
lated by NRF-1 and NRF-2, and all three are sensitive to
the energy needs of the cell [72,73]. Silencing of NRF-1 is
known to lead to lower levels of TFAM and NRF-1
expression is known to increase in response to signals





























m.15028C>A p.Leu94Leu Cytochrome B
m.15043G>A p.Gly99Gly Cytochrome B
There were three significant contrasts in our dataset, two of which, 124 and
121, which represent a single effect. One or more sequence features define
each of the branches, and each is listed here with the resulting protein
change, and the gene the feature is located in.
Figure 3 Multiple sequence alignment of COXIII. Position 21 in the alignment corresponds to position 154 in COXIII. Background colors
correspond to the level of conservation of that position in the alignment. The darker the shade of red, the higher the conservation.
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Figure 4 Pathways between COXIII and known regulators of mtDNA copy number. Here we show all the known pathways between COXIII
and the different genes known to regulate or modify mtDNA copy number.
Figure 5 Multiple sequence alignment of ND2. Position 21 in the alignment corresponds to position 270 in ND2. Background colors are as
described in Figure 3.
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Figure 6 Multiple sequence alignment of COXI. Position 21 in the alignment corresponds to position 196 in COXI. Background colors are as
described in Figure 3.
Figure 7 Pathways between COXI and known regulators of mtDNA copy number. Here we show all the known pathways between COXI
and the different genes known to regulate or modify mtDNA copy number.
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meant to increase energy production [73]. We propose
the following model for m.9667A>G to increase mtDNA
copy number. First, m.9667A>G can decrease the effi-
ciency of complex assembly and decrease overall energy
production of the mitochondria, in response, NRF-1
expression increases, which in turn increases TFAM
expression, and TFAM expression increases mtDNA
copy number.
The second clade significantly associated with higher
mtDNA copy number is defined by branch 50. Branch
50 consists of eight sequence features, six of which are
synonymous changes or located in intergenic regions.
We focused our functional analyses on the two missense
variants. The first is m.5277T>C (p.Phe270Leu) in ND2.
Besides T2, this variant has also been reported in
L1C1A1B individuals [69] and there are no L1C1A1B
individuals in our dataset. This variant is in an uncon-
served region immediately adjacent to a low complexity
region, predicted to not affect protein function, and is
not novel [74,75]. These data suggest this variant is not
functionally deleterious.
In contrast, there is evidence that the second of the two
variants that define this clade, m.6489C>A (p.Leu196Ile),
is functionally deleterious and can explain changes in
mtDNA copy number. m.6489C>A is specific to T2 [69].
This variant in COXI occurs in a highly conserved region
in both COXI and the heme-copper subunit I domain it is
in, and is predicted to affect function. COXI and COXII
form the catalytic center of cytochrome c oxidase (COX),
or complex IV, in the respiratory complex. m.6489C>A is
not a novel mutation and has been reported to lead to
COX deficiency and a destabilization of complex IV [76].
It does appear, however, that a high threshold of mutant
mtDNA is required before a phenotype appears [76,77].
The variant has only been observed in mitochondrial hap-
logroups T2F1 [69] and in our T2 individuals here.
COXI is involved in several pathways that include
known regulators of mtDNA copy number (Figure 7).
Mutations in mtDNA in general, and cytochrome c oxi-
dase malfunction specifically, lead to an increase in reac-
tive oxygen species (ROS) [78]. ROS increase expression
and/or activate protein kinase B (Akt) [79,80], HIF-1
Alpha (HIF1A) [81,82], nuclear factor (erythroid-derived
2)-like 2 (NFE2L2) [83], SP1 transcription factor [84], and
p53 [85,86]. p53 could also be potentially activated by
COXI binding CDC42 [87,88]. Of these genes, two sup-
press TFAM (Akt and HIF1A) [89,90], and three increase
TFAM expression (NFE2L2, SP1, and p53) [91-93].
Conclusions
As we outlined previously, mtDNA copy number is
related to several important human health phenotypes
including several age-related disorders. The identification
of these variants that increase mtDNA copy number has
important implications in understanding the pathological
processes that underlie these phenotypes. We have used
bioinformatics analyses to generate hypotheses for the
mechanisms by which these variants influence mtDNA
copy number, successfully generating several hypotheses.
Future work to characterize these mechanisms will pro-
vide important insights into the effects of mitochondrial
genomic variation on mtDNA copy number and broader
human phenotypes.
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